SCHEMBL19981997

SCHEMBL19981997

COC(=O)C(O)C(O)(CCCCC(C)C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ACACB O00763 1/20 0.37
ACACA Q13085 1/20 0.37
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
KDM4C Q9H3R0 2/20 0.33
KDM4A O75164 1/20 0.33
PHF8 Q9UPP1 1/20 0.33
KDM2A Q9Y2K7 1/20 0.33
ZDHHC7 Q9NXF8 1/20 0.33
CPT2 P23786 1/20 0.33
ACLY P53396 1/20 0.33
ABCB1 P08183 1/20 0.32
BLM P54132 2/20 0.32
HSPD1 P10809 1/20 0.32
HSPE1 P61604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16644324 0.89 CPT2 (0.35) MEN1HPGDRECQLKMT2AHSD17B10
SCHEMBL13664757 0.76 USP2 (0.39) USP2LMNACA1CA2
SCHEMBL11925943 0.73 LMNA (0.34) MEN1HPGDRECQLKMT2AHSD17B10
SCHEMBL13520456 0.72 USP2 (0.31) MEN1KMT2AUSP2LMNA
SCHEMBL27740654 0.69 ACACB (0.46) MEN1KMT2AACACBACACALMNA
SCHEMBL5956798 0.69 ACACB (0.46) MEN1KMT2AACACBACACALMNA
SCHEMBL8376516 0.69 ACACB (0.50) MEN1KMT2AACACBACACALMNA
SCHEMBL6284476 0.68 BLM (0.50) MEN1HPGDRECQLKMT2AHSD17B10
SCHEMBL28126694 0.68 BLM (0.47) LMNAKDM4CKDM4APHF8KDM2A
SCHEMBL5551502 0.68 ACACB (0.44) MEN1KMT2AACACBACACALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2146690-B1 ORAL CEPHALOTAXINE DOSAGE FORMS TEVA PHARMACEUTICALS INT GMBH (CH) 2018-03-21 EP disclosed